These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 901625)
1. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia. Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625 [TBL] [Abstract][Full Text] [Related]
2. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia. Olsson AG; Lang PD Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174 [TBL] [Abstract][Full Text] [Related]
3. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia. Olsson AG; Rössner S; Walldius G; Carlson LA Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607 [TBL] [Abstract][Full Text] [Related]
4. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)]. Weisweiler P; Schwandt P Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601 [TBL] [Abstract][Full Text] [Related]
5. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Olsson AG; Lang PD Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175 [TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia. Kłosiewicz-Latoszek L; Szostak WB Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543 [TBL] [Abstract][Full Text] [Related]
7. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia. Olsson AG; Orö L Atherosclerosis; 1982 Apr; 42(2-3):229-43. PubMed ID: 6951582 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate. Lehtonen A; Viikari J Atherosclerosis; 1979 May; 33(1):49-58. PubMed ID: 223601 [TBL] [Abstract][Full Text] [Related]
9. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787 [TBL] [Abstract][Full Text] [Related]
11. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia. Vessby B; Hedstrand H; Olsson U Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321 [TBL] [Abstract][Full Text] [Related]
12. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. Kesäniemi YA; Grundy SM JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883 [TBL] [Abstract][Full Text] [Related]
14. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
15. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes. Olsson AG; Ekelund LG; Carlson LA Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796 [TBL] [Abstract][Full Text] [Related]
16. Differences among hyperlipoproteinaemic subjects in the response of lipoprotein lipids to resin therapy. Miller NE; Nestel PJ Eur J Clin Invest; 1975 Jun; 5(3):241-7. PubMed ID: 1149783 [TBL] [Abstract][Full Text] [Related]
17. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia. Orö L; Olsson AG; Rössner S; Carlson LA Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986 [TBL] [Abstract][Full Text] [Related]
18. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition. Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871 [TBL] [Abstract][Full Text] [Related]
19. On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. Simons LA; Hickie JB; Balasubramaniam S Atherosclerosis; 1985 Jan; 54(1):75-88. PubMed ID: 3888229 [TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction. Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]